Ja. Toretsky et al., THE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR IS REQUIRED FOR EWS FLI-1 TRANSFORMATION OF FIBROBLASTS/, The Journal of biological chemistry, 272(49), 1997, pp. 30822-30827
Ewing's family of tumors is characterized by a well described reciproc
al translocation, t(11;22)(q24;q12), which produces a fusion protein (
EWS/FLI-1) that transforms mouse fibroblasts. The EWS/FLI-1 fusion pro
tein has been shown to act as a potent chimeric transcription factor.
Overexpression of insulin like growth factor-I receptor (IGF-IR) has b
een implicated in many tumor models as playing a role in cell growth a
nd tumorigenesis. In addition, blockade of the IGF-IR inhibits the gro
wth of Ewing's family of tumors cells. Therefore, we first studied whe
ther the presence of the IGF-IR is required for transformation by the
EWS/FLI-1 fusion protein. To perform this study, we used two previousl
y described fibroblast cell lines, R- and W, derived from an IGF-IR kn
ockout mouse and a wild-type littermate, respectively. Neither W nor R
-cells without the fusion protein formed soft agar colonies. However,
W clones expressing the fusion message (WF cells) formed soft agar col
onies, whereas R-clones expressing the fusion message (R-F cells) did
not form soft agar colonies. Because the IGF-IR is required for EWS/FL
I-1 transformation, we chose to investigate whether altered signaling
occurs from the IGF-IR when the EWS/FLI-1 fusion is present. WF cells
demonstrated a greater degree of ligand-stimulated insulin receptor su
bstrate-1 phosphorylation when compared with W cells, suggesting that
expression of the EWS/FLI-1 fusion protein alters the IGF-IR signaling
pathway.